Inosinate phosphorylation

The nucleoside monophosphate kinases do not appear to catalyze the phosphorylation of inosinate. Hershko et al. 19) did not detect inosinate phosphorylation in stroma-free hemolysates of human erythrocytes. 

Figure 34-2 illustrates the intermediates and reactions for conversion of a-D-ribose 5-phosphate to inosine monophosphate (IMP). Separate branches then lead to AMP and GMP (Figure 34-3). Subsequent phosphoryl transfer from ATP converts AMP and GMP to ADP and GDP. Conversion of GDP to GTP involves a second phosphoryl transfer from ATP, whereas conversion of ADP to ATP is achieved primarily by oxidative phosphorylation (see Chapter 12).

Adenosine metabolism (Fig. 12.2) is reviewed in Dunwiddie Masino (2001) and Ribeiro et al. (2002). The phosphorylation of intracellular adenosine to AMP is catalyzed by adenosine kinase. Intracellularly, adenosine can also be deami-nated to inosine by adenosine deaminase. Free intracellular adenosine is normally low. Excess adenosine, which cannot be regenerated to ATP, is extruded to the extracellular space by equilibrative nucleoside transporters (ENTs) in the cell membrane. During electrical stimulation or energy depletion, adenosine is... 

The amino group now provides the nucleus for purine ring formation, an extended series of reactions we shall not describe. The first-formed purine product is inosine 5 -phosphate (IMP), which leads to either AMP or GMP these require amination at alternative sites, and utilize either GTP- or ATP-dependent reactions for amination. GTP or ATP (as appropriate) will also be required for further phosphorylations to produce the nucleotide triphosphates. 

This enzyme [EC 2.7.1.73] catalyzes the ATP-dependent phosphorylation of inosine to generate IMP and ADP. 

Pharmacokinetics Rapidly cleared from the circulation via cellular uptake, primarily by erythrocytes and vascular endothelial cells. Extensively distributed and rapidly metabolized either via phosphorylation to adenosine monophosphate by adenosine kinase, or via deamination to inosine by adenosine deaminase in the cytosol. Ralf-life 10 sec. 

In animals and in many bacteria, PEP is formed by decarboxylation of oxaloacetate. In this reaction, which is catalyzed by PEP carboxykinase (PEPCK), a molecule of GTP, ATP, or inosine triphosphate captures and phosphorylates the enolate anion generated by the decarboxylation (Eq. 13-46).252 The stereochemistry is such that C02 departs from the si face of the forming enol.253 The phospho group is transferred from GTP with inversion at the phosphorus atom 254 The enzyme requires a divalent metal ion, preferably Mn2+. 

Didanosine is a synthetic purine nucleoside analog that inhibits the activity of reverse transcriptase in HIV-1, HIV-2, other retroviruses and zidovudine-resistant strains. A nucleobase carrier helps transport it into the cell where it needs to be phosphorylated by 5 -nucleoiidase and inosine 5 -monophosphate phosphotransferase to didanosine S -monophosphate. Adenylosuccinate synthetase and adenylosuccinate lyase then convert didanosine 5 -monophosphate to dideoxyadenosine S -monophosphate, followed by its conversion to diphosphate by adenylate kinase and phosphoribosyl pyrophosphate synthetase, which is then phosphorylated by creatine kinase and phosphoribosyl pyrophosphate synthetase to dideoxyadenosine S -triphosphate, the active reverse transcriptase inhibitor. Dideoxyadenosine triphosphate inhibits the activity of HIV reverse transcriptase by competing with the natural substrate, deoxyadenosine triphosphate, and its incorporation into viral DNA causes termination of viral DNA chain elongation. It is 10-100-fold less potent than zidovudine in its antiviral activity, but is more active than zidovudine in nondividing and quiescent cells. At clinically relevant doses, it is not toxic to hematopoietic precursor cells or lymphocytes, and the resistance to the drug results from site-directed mutagenesis at codons 65 and 74 of viral reverse transcriptase. 

The 3- and 5-phosphates of D-ribose have both been obtained through the hydrolysis of naturally occurring ribosides. In 1908 Levene and Jacobs122 subjected the barium salt of inosinic acid to acid hydrolysis and obtained a pentose phosphate as its barium salt. Shortly thereafter the same authors78 showed that, under the conditions which normally convert a pentose to a pentaric acid, this phosphate was oxidized only to a phosphorylated D-ribonic acid and it was evident, therefore, that... 

Phosphorylation of XLVII with phosphorus oxychloride in pyridine solution, followed by hydrolysis to remove the methyl and isopropylidene residues, gave D-ribose 5-phosphate (XLVIII) which, as its barium salt, was found to be identical with the barium salt of the D-ribose phosphate from inosinic acid. By way of further confirmation of the structure of D-ribose 5-phosphate, Levene, Harris and Stiller129 showed that in methanolic hydrogen chloride solution both the natural and synthetic material mutarotated in a manner characteristic of a sugar which can form only a furanoside. 

Cyclic acetals of the naturally occurring N-ribofuranosides have been prepared. Levene and Tipson156 found that inosine will condense with acetone in the presence of zinc chloride to give a monoisopropylidene derivative. Since this compound afforded a monotosyl ester in which the tosyloxy group was readily replaced by iodine, it was assigned structure CYI. Phosphorylation of CYI followed by hydrolytic removal... 

Figure 10.11 AMP can be formed by adenosine kinase (1) in a reaction that uses ATP as the phosphate donor and forms ADP as the second reaction product. Alternatively, AMP can be deaminated to IMP by the enzyme AMP deaminase (2) and converted to inosine (INO) by a 5 -nucleotidase activity (3). Finally, AMP can be phosphorylated to ADP by the enzyme AMP kinase (4).

A few steps convert inosinate into either AMP or GMP (Figure 25,9). Adenylate is synthesized from inosinate by the substitution of an amino group for the carbonyl oxygen atom at C-6. Again, the addition of aspartate followed by the elimination of fumarate contributes the amino group. GXP, rather than ATP, is the phosphoryl-group donor in the synthesis of the adenylosuccinate intermediate from inosinate and aspartate. In accord with the use of GTP, the enzyme that promotes this conversion, adenylsuccinate synthase, is structurally related to the G-protein family and does not contain an ATP-grasp domain. The same enzyme catalyzes the removal of fumarate from adenylosuccinate in the synthesis of adenylate and from 5-aminoimidazole-4-jV-succinocarboxamide ribonucleotide in the synthesis of inosinate. 

On phosphorylation of isopropylidene-inosine, followed by hydrolysis of the acetone residue, muscle inosinic acid (which, as will be seen later, is definitely known to be 5-phospho-inosine) is formed. This confirms the above formulations for isopropylidene-inosine and inosine. 

Finally, muscle inosinic acid itself was synthesized by Levene and Tipson. This was the first (partial) synthesis of a naturally occurring nucleotide. Phosphorylation of 2,3-isopropylidene-inosine, the structure of which has already been discussed, gave the corresponding 5-phospho derivative, from which the isopropylidene group was cautiously hydrolyzed, yielding 5-phosphoinosine which proved to be identical with muscle inosinic acid. 

Gulland and Jackson performed some experiments with 5-nucleotidase, a highly specific enzyme which dephosphorylates 5-phospho-adenosine and -inosine but not" 5-phospho-guanosine and -uridine it is apparently not yet known whether the enzyme dephosphorylates 5-phos-pho-cytidine. They found that a mixture of phosphodiesterase with 5-nucleotidase liberates 35% of the total phosphorus as inorganic phosphate, and therefore decided that two or more of the phosphoryl groups may be attached at position (5) of the ribose units. The 35% dephosphorylation, intermediate between 25 and 50%, was explained as the result of simultaneous, competitive diesterase action at A and B, on two or more phosphoryl groups ... 

Mercaptopurine is not active until it is anabolized to the phosphorylated nucleotide. In this form, it comgietes with endogenous ribonucleotides for enzymes that convert ino-sinic acid into adenine- and xanthinc-ba.sed ribonucleotides. Furthermore, it is incoiporated into RNA. where it inhibits further RNA synthesis. One of its main metabolites is 6-mcthylmercaptopurine ribonucleotide, which also is a potent inhibitor of the conversion of inosinic acid into purines. - "... 

Nucleoside Cyclic Pyrophosphates. Extensive work has been carried out by Matsuda et al. in their efforts to synthesise chemically stable cyclic adenosine diphosphate ribose (cADPR) analogues. The carbocyclic inosine analogue (83) was first prepared through an efficient cyclisation of an 8-bromo-A-1 -[5"-(phosphoryl)carbocyclic-ribosyl]inosine 5 -phenylthiophos-... 

---